Randomized Clinical Trial on Transanal Irrigation

Low Anterior Resection Syndrome Clinical Trial

Official title:

Randomized Clinical Trial Assessing the Effect of Transanal Irrigation With Cone Catheter Versus Conservative Bowel Management on Symptoms of Low Anterior Resection Syndrome After Rectal Resection

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04586634
• Other study ID #: CP327
• Status: Completed
• Phase: N/A
• Start date: January 21, 2020
• Est. completion date: December 10, 2021

Study information

• Verified date: October 2020
• Source: Coloplast A/S
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Objective The primary objective is to demonstrate superiority of the Peristeen cone catheter compared to standard of care.

The secondary objective is to investigate quality of life and different benefits and aspects of treatment and satisfaction with the Peristeen cone catheter.

Design of the investigation This is a randomised, open-label, parallel investigation comparing the Peristeen cone catheter with standard of care in subjects with major LARS (LARS score ≥ 30). Each subject will be enrolled for a study duration of 12 weeks. Subjects will be randomized to the treatments stratified by neo-adjuvant radiotherapy.

The comparator in this study will be current standard of care for patients with LARS which is conservative bowel management. This is defined as: Supportive therapy according to the individual treatment protocols available at each participating site.

Primary endpoint and secondary endpoints

Primary endpoint:

• LARS score, obtained from the LARS score questionnaire*

Secondary endpoints:

• Number of subjects with Major LARS*

• FIQL Score - scale 1, Modified American Society for Colorectal Surgeons Questionnaire*

• FIQL Score - scale 2, Modified American Society for Colorectal Surgeons Questionnaire*

• FIQL Score - scale 3, Modified American Society for Colorectal Surgeons Questionnaire*

• FIQL Score - scale 4, Modified American Society for Colorectal Surgeons Questionnaire*

• EQ-5D-5L - utility score*

• EQ-5D-5L - VAS score (scale 0-10 cm)*

• Satisfaction with treatment (scale 0-10 cm)*

• Number of adverse events* *All endpoints are measured per subject at study termination

Recruitment information / eligibility

• Status: Completed
• Enrollment: 32
• Est. completion date: December 10, 2021
• Est. primary completion date: December 10, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

1. Be at least 18 years of age and have full legal Capacity

2. Have given written informed consent

3. Be mental and physical capable to perform transanal irrigation with cone catheter

4. Have a LARS score = 30 after rectal resection

5. Be treated according to individual treatment protocol for conservatory bowel management at participating site

6. Have proof of complete healing of the anastomosis by endoscopy or radiology before stoma closure

7. At least 3-months from last surgery in colorectum

8. Be evaluated to be suitable for transanal Irrigation procedure with a cone catheter by endoscopy, defecography or comparable procedure

Exclusion Criteria:

1. Active/recurrent colorectal cancer

2. Leaking anastomosis

3. Known anal or colorectal stenosis

4. Within 4 weeks of endoscopic polypectomy

5. Ischaemic colitis

6. Acute inflammatory bowel disease

7. Acute diverticulitis

8. Current or planned pregnancy

Related Conditions & MeSH terms

• Low Anterior Resection Syndrome
• Syndrome

Intervention

Device:
• Peristeen cone catheter
The active intervention is the Peristeen cone catheter device. The comparator in this investigation is current standard of care for patients with LARS which is conservative bowel management.

Locations

Country	Name	City	State
Denmark	Coloplast A/S	Humlebæk

Sponsors (2)

Lead Sponsor	Collaborator
Coloplast A/S	MedPass International

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	LARS score	obtained from the LARS score questionnaire	measured pr subject at study termination after 12 weeks